Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Oppenheimer

UnitedHealth Is the Worst Dow Jones Stock Thursday. Here's Why

UnitedHealth is putting pressure on the 30-stock index Thursday after the insurance giant reported a rare revenue miss. This is what you need to know.

Kiplinger

Broadcom, IBD Stock Of The Day, Showing Strength After Breakout

Broadcom is the IBD Stock Of The Day as shares of the fabless chipmaker and infrastructure software provider show strength in a turbulent market.

Investors Business Daily

What's in Store for the Bull Market in 2025?

The current bull market recently turned two and most – but not all – Wall Street pros expect the party to continue in the new year.

Kiplinger

From analysis to the latest developments in health,
read the most diverse news in one place.

Christopher Nolan’s next film announced as ‘mythic action epic’ The Odyssey

The Oppenheimer director’s adaptation of Homer is scheduled for release in the summer of 2026, and will feature Tom Holland, Matt Damon, Anne Hathaway and Zendaya

The Guardian - UK

Breaking Down Where Wall Street Sees the S&P 500 Going in 2025

Wall Street price targets for the S&P 500's year-end 2025 level are out. See where analysts predict the market will go next year.

MarketBeat

XPO Stock Gains Momentum as U.S. Trade Outlook Evolves

XPO is at the forefront of the transportation and logistics business, with shares that have spiked throughout 2024; here's a glimpse of what may be to come.

MarketBeat

Analyst Sees 'Buying Opportunity' After Uber Stock Sell-Off On Waymo, Tesla Robotaxi Concerns

An Uber stock analyst with Oppenheimer says the ride-hail market leader's recent sell-off is an opportunity for investors.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Christopher Nolan names ‘masterful’ epic as his favourite film of 2024

Nolan praises Ridley Scott for allowing ‘Gladiator 2 to speak for itself, once again showing us who we are simply by inviting us to enjoy the crazy inflationary ride’

The Independent UK

Christopher Nolan and Christian Horner to be honoured at investiture ceremony

The Inception director will receive a knighthood from the King on the same day that his wife, film producer Emma Thomas, receives a damehood.

Evening Standard

Guy Pearce claims Warner Bros exec barred him from working with Christopher Nolan again

Pearce starred in Nolan’s breakout neo-noir ‘Memento’ in 2000

The Independent UK

Why Adobe Stock Is Down After Its Earnings Beat

Adobe stock is lower Thursday despite the tech giant beating expectations for its fiscal 2024 fourth quarter. Here's what you need to know.

Kiplinger

Lululemon's Strong Earnings and Share Buyback Push Analysts to Increase Price Forecast

Analysts raise Lululemon's price targets, citing strong Q3 results, international growth, product innovation, and future expansion opportunities.

Benzinga

UiPath 'Story Remains A Work In Progress': Analysts Want To See More After Q3 Results, 'Sustained Execution Remains Key'

Analysts see near-term concerns for UiPath after the company's Q3 results.

Benzinga

Ulta Beauty Stock Gets a Much-Needed Boost After Earnings

Beaten-down Ulta Beauty stock is notably higher Friday after the cosmetics retailer's strong earnings report and encouraging outlook.

Kiplinger

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Marvell Technology Posts Solid Q3 Beat: Analysts Raise Forecasts, Expect 40%-50% Earnings Growth

Marvell Technology reported upbeat earnings amid exciting earnings season. Analysts raised their price targets, expecting strong growth.

Benzinga

Analyst Expectations For Bank of America's Future

Across the recent three months, 14 analysts have shared their insights on Bank of America (NYSE:BAC), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

Unveiling 13 Analyst Insights On Clearwater Analytics Hldg

Across the recent three months, 13 analysts have shared their insights on Clearwater Analytics Hldg (NYSE:CWAN), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

Demystifying Agilysys: Insights From 8 Analyst Reviews

Analysts' ratings for Agilysys (NASDAQ:AGYS) over the last quarter vary from bullish to bearish, as provided by 8 analysts.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Zscaler Posts Q1 Beat: 8 Analysts Express Concern Around CFO Retirement, Guidance

Zscaler shares tanked despite upbeat Q1 results. The company raised its fiscal-year guidance and announced the departure of its CFO.

Benzinga

Decoding 10 Analyst Evaluations For JPMorgan Chase

Analysts' ratings for JPMorgan Chase (NYSE:JPM) over the last quarter vary from bullish to bearish, as provided by 10 analysts.

Benzinga

Expert Ratings For Citigroup

In the preceding three months, 11 analysts have released ratings for Citigroup (NYSE:C), presenting a wide array of perspectives from bullish to bearish.

Benzinga

Spotlight on AppLovin: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on AppLovin.

Barchart

Are Wall Street Analysts Bullish on Lululemon Stock?

Despite Lululemon struggling to keep up with the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock's outlook.

Barchart

1 AI Stock to Buy and Hold for Long-Term Growth

Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors

Kiplinger

Target Is the Worst S&P 500 Stock After Earnings. Here's Why

Target stock is down big after the retailer missed expectations for its third quarter and slashed its full-year outlook. Here's what Wall Street is saying.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.